Research reading
Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale demand and the China (CHN) to MMR (MMR) lane
MMR (MMR) reported $18.9M of medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale imports in 2024. China (CHN) accounted for 21.6% of the observed market and reported $4.1M in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +4.3% buyer growth and +0.2% exporter growth. The page separates reported values from projections and indicators.
